Chowell, G, Miller, MA, Viboud, C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiology and Infection
2008; 136: 852–864.
Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report. Recommendations and Reports
2010; 59: 1–62.
Carrat, F, Flahault, A. Influenza vaccine: the challenge of antigenic drift. Vaccine
2007; 25: 6852–6862.
Wood, JM. Developing vaccines against pandemic influenza. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
2001; 356: 1953–1960.
Osterholm, MT, et al.
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infectious Diseases
2012; 12: 36–44.
Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. Recommendations and Reports
2011; 60: 1–24.
Nicholson, KG, et al.
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Lancet
2000; 355: 1845–1850.
Goldstein, E, et al.
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infectious Diseases. Published online: 20 July 2009. doi:10.1186/1471-2334-10-211.
Halloran, ME, et al.
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American Journal of Epidemiology
2007; 165: 212–221.
Ng, S, et al.
Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clinical Infectious Diseases
2010; 50: 707–714.
Pebody, RG, et al.
Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom. Emerging Infectious Diseases
2011; 17: 990–999.
Carrat, F, et al.
A ‘small-world-like’ model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Medicine. Published online: 23 October 2006. doi:10.1186/1741-7015-4-26.
Ferguson, NM, et al.
Strategies for mitigating an influenza pandemic. Nature
2006; 442: 448–452.
Pepin, KM, Riley, S, Grenfell, BT. Effects of influenza antivirals on individual and population immunity over many epidemic waves. Epidemiology and Infection
2013; 141: 366–376.
Longini, IM Jr., et al.
Containing pandemic influenza with antiviral agents. American Journal of Epidemiology
2004; 159: 623–633.
Black, AJ, et al.
Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza. Journal of the Royal Society Interface. Published online: 6 February 2013. doi:10.1098/rsif.2012.1019.
Bansal, S, Pourbohloul, B, Meyers, LA. A comparative analysis of influenza vaccination programs. PLoS Medicine
2006; 3: 1816–1825.
Meyers, LA, et al.
Network theory and SARS: predicting outbreak diversity. Journal of Theoretical Biology
2005; 232: 71–81.
Bansal, S, et al.
The shifting the demographic landscape of pandemic influenza.
PLoS ONE. Published online: 26 February 2010. doi:10.1371/journal.pone.0009360.
Frost, WH. Statistics of influenza morbidity: with special reference to certain factors in case incidence and case fatality. Public Health Reports
1920; 36: 584–597.
Mills, CE, Robins, JM, Lipsitch, M. Transmissibility of 1918 pandemic influenza. Nature
2004; 432: 904–906.
Yang, Y, et al.
The transmissibility and control of pandemic influenza A (H1N1) virus. Science
2009; 326: 729–733.
Simpson, CR, et al.
Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. Lancet Infectious Diseases
2012; 12: 696–702.
Ng, S, et al.
Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. Journal of Infectious Diseases
2013; 208: 1320–1324.
Allard, A, et al.
Heterogeneous bond percolation on multitype networks with an application to epidemic dynamics.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. doi:10.1103/PhysRevE.79.036113. Published online: March 2009.
Centers for Disease Control and Prevention. Self-reported influenza vaccination coverage trends 1989–2008 among adults by age group, risk group, race/ethnicity, health-care worker status, and pregnancy status, United States, National Health Interview Survey (NHIS) [Table]. Atlanta: CDC (updated 26 September 2012) (http://www.cdc.gov/flu/fluvaxview/trends.htm). Accessed 7 August 2013.
Atkins, CY, et al.
Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerging Infectious Diseases
2011; 17: 1591–1598.
Yoshida, M, et al.
Seasonal influenza surveillance using prescription data for anti-influenza medications. Japanese Journal of Infectious Diseases
2009; 62: 233–235.
Cowling, BJ, et al.
Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial. Clinical Infectious Diseases
2012; 55: 695–702.
Cowling, BJ, et al.
Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clinical Infectious Diseases
2010; 51: 1370–1379.
Viboud, C, Simonsen, L. Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus?
PLoS Medicine. Published online: 6 April 2010. doi:10.1371/journal.pmed.1000259.
Moghadas, SM, et al.
Population-wide emergence of antiviral resistance during pandemic influenza.
PLoS ONE. Published online: 19 March 2008. doi:0.1371/journal.pone.0001839.
Longini, IM Jr., Halloran, ME. Strategy for distribution of influenza vaccine to high-risk groups and children. American Journal of Epidemiology
2005; 161: 303–306.
Medlock, J, Galvani, AP. Optimizing influenza vaccine distribution. Science
2009; 325: 1705–1708.
van den Dool, C, et al.
The effects of influenza vaccination of health care workers in nursing homes: insights from a mathematical model.
PLoS Medicine. Published online: 28 October 2008. doi:10.1371/journal.pmed.0050200.
Biggerstaff, M, et al.
Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009–2010.
American Journal of Public Health. Published online: October 2012. doi:10.2105/ajph.2012.300651.
Chao, DL. Modelling the global transmission of antiviral-resistant influenza viruses. Influenza and Other Respiratory Viruses
2013; 7: 58–62.